HMS Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,895
| Closed | -$239K | – | 102 |
|
2022
Q3 | $239K | Hold |
2,895
| – | – | 0.15% | 108 |
|
2022
Q2 | $275K | Buy |
2,895
+573
| +25% | +$54.4K | 0.14% | 100 |
|
2022
Q1 | $273K | Hold |
2,322
| – | – | 0.11% | 112 |
|
2021
Q4 | $301K | Hold |
2,322
| – | – | 0.13% | 109 |
|
2021
Q3 | $263K | Hold |
2,322
| – | – | 0.12% | 115 |
|
2021
Q2 | $240K | Buy |
+2,322
| New | +$240K | 0.11% | 119 |
|
2020
Q4 | – | Sell |
-3,138
| Closed | -$250K | – | 113 |
|
2020
Q3 | $250K | Hold |
3,138
| – | – | 0.1% | 104 |
|
2020
Q2 | $217K | Buy |
+3,138
| New | +$217K | 0.1% | 104 |
|
2020
Q1 | – | Sell |
-3,138
| Closed | -$244K | – | 84 |
|
2019
Q4 | $244K | Hold |
3,138
| – | – | 0.1% | 92 |
|
2019
Q3 | $230K | Hold |
3,138
| – | – | 0.09% | 109 |
|
2019
Q2 | $193K | Hold |
3,138
| – | – | 0.08% | 92 |
|
2019
Q1 | $200K | Sell |
3,138
-3,942
| -56% | -$251K | 0.09% | 92 |
|
2018
Q4 | $361K | Hold |
7,080
| – | – | 0.18% | 87 |
|
2018
Q3 | $411K | Hold |
7,080
| – | – | 0.2% | 91 |
|
2018
Q2 | $344K | Buy |
+7,080
| New | +$344K | 0.19% | 97 |
|
2016
Q4 | – | Sell |
-25,809
| Closed | -$1.04M | – | 81 |
|
2016
Q3 | $1.04M | Buy |
+25,809
| New | +$1.04M | 1.03% | 32 |
|